Arisglobal Acquires Boehringer Ingelheim'S Signal Analytics Engine, Bringing Enhanced And Unmatched Pharmacovigilance Capabilities To Life Sciences Industry

May 11, 2022•about 3 years ago

Acquiring Company

ArisGlobal

Acquired Company

Signal Analytics Engine

WalthamSoftwareScience And Engineering

Description

ArisGlobal, the global market leader in drug safety solutions worldwide, and Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced the acquisition of Boehringer Ingelheim's digital innovation, BRASS, by ArisGlobal. This data insights engine will be integrated into ArisGlobal's technology platform, LifeSphere®, under the name of LifeSphere Clarity, and will play a key role in driving industry-wide advancement of pharmacovigilance and patient safety.

Company Information

Company

ArisGlobal

Location

Waltham, Massachusetts, United States

About

ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans almost 40 years, LifeSphere® boosts efficiency, ensures compliance, and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture.

Related People

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed